Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1177156)
Howard Hughes Medical Institute (OPP1099295)
Application of Novel Transgenic technology & Inherited Symbionts to Vector Control (AVPP0027/1)
Consortium for Advanced Research and Training in Africa (087547/Z/08/Z)
Received: 16 October 2020
Accepted: 23 February 2021
First Online: 6 March 2021
: Ethical approvals for this project was obtained from Ifakara Health Institute’s Institutional Review Board (Protocol ID: IHI/IRB/EXT/No: 015–2018) and the Medical Research Coordinating Committee (MRCC) at the National Institute for Medical Research (Protocol ID: NIMR/HQ/R.8a/Vol.IX/2697), in Tanzania, as well as University of the Witwatersrand (UW) in South Africa (Clearance certificate No. M180820). Written consent was obtained from all participants of this study after they had been informed of the purpose and procedure of the discussions. Permission to publish this study was obtained from NIMR, ref: NIMR/HQ/P.12 VOL XXXI71.
: The authors declare no competing interests.